Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
Predictive value of on-treatment response during full-dose antiviral therapy of patients with hepatitis C virus cirrhosis and portal hypertension
Journal of Internal Medicine, 10/28/09
Giannini EG et al. – Full–dose antiviral therapy with PEG–IFN and ribavirin can be safely carried out even in patients with compensated, fully established cirrhosis and portal hypertension. Selecting patients on the basis of HCV genotype and viral load, and application of on–treatment stopping rule may help rationalize treatment in patients who are unlikely to obtain SVR.
Related Articles
Sporadic cases of acute autochthonous hepatitis E virus infection in Southwest Germany
Journal of Clinical Virology, 11/16/09
Relevance Score: 91%
Liver enzyme abnormalities in systemic lupus erythematosus: A focus on toxic hepatitis
Rheumatology International, 11/13/09
Relevance Score: 91%
De novo hepatocellular carcinoma in a liver graft with sustained hepatitis C virus clearance after living donor liver transplantation
Liver Transplantation, 10/30/09
Relevance Score: 91%
Reactivation of Hepatitis B With Reappearance of Hepatitis B Surface Antigen After Chemotherapy and Immunosuppression
Clinical Gastroenterology and Hepatology, 10/09/09
Relevance Score: 91%
FOXP3 Expression in Hepatitis C Virus-Specific CD4+ T Cells During Acute Hepatitis C
Gastroenterology, 10/06/09
Relevance Score: 91%
Today in Antimicrobials...keeping you current
Receive free subspecialty "5-minute updates" via email
Antiretroviral Therapy With Heart
American Journal of Therapeutics, 11/25/09
Daptomycin Versus Other Antimicrobial Agents for the Treatment of Skin and Soft Tissue Infections: A Meta-Analysis
Annals of Pharmacotherapy, 11/25/09
Lopinavir Cerebrospinal Fluid Steady-State Trough Concentrations in HIV-Infected Adults
Annals of Pharmacotherapy, 11/25/09
Today in GI Infectious Disease...keeping you current
Receive free subspecialty "5-minute updates" via email
Prevalence of plasmid-mediated quinolone resistance determinants in Enterobacteriaceae from Tunisia
Clinical Microbiology and Infection, 11/25/09
A unified approach to molecular epidemiology investigations: tools and patterns in California as a case study for endemic shigellosis
BMC Infectious Diseases, 11/25/09
Pyoderma Gangrenosum in Crohn's Disease: Unusual Presentation and Management
Case Reports in Gastroenterology, 11/25/09
Today in Hepatitis...keeping you current
Receive free subspecialty "5-minute updates" via email
Different models of HBeAg seroconversion predicated by on-treatment ALT and HBV DNA profiles
Journal of Viral Hepatitis, 11/25/09
Plasma HCV-RNA decline in the first 48 h identifies hepatitis C virus mono-infected but not HCV/HIV-coinfected patients with an undetectable HCV viral load at week 4 of peginterferon-alfa-2a/ribavirin therapy
Journal of Viral Hepatitis, 11/25/09
Mutation frequency of NS5A in patients vertically infected with HCV genotype 1 predicts sustained virological response to peginterferon alfa-2b and ribavirin combination therapy
Journal of Viral Hepatitis, 11/25/09
Article Search
Sponsor


See Latest Articles


